ro 15-4513 has been researched along with Alloxan Diabetes in 1 studies
Ro 15-4513: a partial inverse agonist of benzodiazepine receptors
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, S | 1 |
| Hirano, S | 1 |
| Kamei, J | 1 |
1 other study available for ro 15-4513 and Alloxan Diabetes
| Article | Year |
|---|---|
Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice.
Topics: Amphetamines; Animals; Azides; Behavior, Animal; Benzodiazepines; Bicuculline; Diabetes Mellitus, Ex | 2006 |